Ultrasonic debridement with stem cell therapy of suspensory branch desmitis in an equine patient

2Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Ultrasonic debridement as a treatment for tendinopathy and desmitis is a relatively new approach in orthopedic surgery. Previously only used in limited cases, this procedure shows promise for treating ligament-bone and tendon-bone interface injuries. We present a case study of a 2-yr-old thoroughbred male horse, unable to train due to recalcitrant symptoms after extensive conservative management of suspensory branch desmitis. It was then treated with ultrasonic debridement and concurrent manubrial stem cell autograft injection, to treat the ultrasound visualized lesion. Post-surgically, the patient recovered quickly, began training within 16 wk, and went onto win several races. Repeat ultrasound imaging reveals a complete restoration of the internal fiber architecture of the ligament. With a 3-yr follow-up, there has been consistent training and race performance with no re-injury. This study is the first to document the successful outcome of ultrasonic debridement with concurrent stem cell injection in the treatment of equine desmitis.

Cite

CITATION STYLE

APA

Kamineni, S., Ruggles, A., & Ashfaq, H. (2019). Ultrasonic debridement with stem cell therapy of suspensory branch desmitis in an equine patient. Open Veterinary Journal, 9(1), 54–57. https://doi.org/10.4314/ovj.v9i1.10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free